Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,567,360
-
Total 13F shares
-
27,989,545
-
Share change
-
+101,320
-
Total reported value
-
$864,603,729
-
Price per share
-
$30.89
-
Number of holders
-
74
-
Value change
-
-$826,724
-
Number of buys
-
40
-
Number of sells
-
29
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q2 2021
As of 30 Jun 2021 ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,989,545 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, EcoR1 Capital, LLC, RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., WASATCH ADVISORS INC, and AMERIPRISE FINANCIAL INC.
This table shows 74 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.